Information technology is ushering in a new paradigm for the healthcare sector. This is fundamentally changing how and where medical services are rendered, and decisions are made. From…
Pharmaceuticals
Naturally Splendid (NSP.V) has provided an update regarding a Health Canada approved clinical trial and strategic outlook for the development of Cavaltinib™. “We have been working with Franco and…
When a ‘devastating’ expose on a company opens with the line ‘We are short this company’, I have to say, I find it hard to read much further. To…
Revive Therapeutics (RVV.C) provided an update on their FDA Phase III clinical trial to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate Covid-19. …
Novamind (NM.C) announced that their wholly-owned subsidiary, Cedar Clinical Research (CCR), has been selected by Merck to be a key research site for a clinical trial focused on treatment-resistant…
News this week that Canntab Therapeutics (PILL.C) received an Australian patent for their hard-pressed cannabis pill tech, to match those received earlier in North America, didn’t launch the stock…
Khiron Life Sciences (KHRN.V) has opened two additional satellite Zerenia clinics in Colombia following the success of its initial small format clinic in Medellin. “We are off to a…
Heritage Cannabis (CANN.C) has been granted an export license by Health Canada. The license will permit the Company to export cannabis products to Brazil marking the first-ever license granting…
Red Light Holland (TRIP.C) has completed the sale and import of the Company’s iMicrodose psychedelic truffles packs from the Netherlands to Canada. The transaction was made possible via the…
Medexus common stock reached a high of $7.70 per share due to a positive market reaction to their latest press release. At a time where the general economy and…